Calyxo: Funding, Investors & Team (Oct 2026)
Calyxo, Inc. is an innovative healthcare company that focuses on enhancing the treatment of kidney stones, a prevalent and distressing condition that currently requires significant healthcare resources. Established in 2016, Calyxo is guided by experienced leaders and investors who have successfully introduced groundbreaking solutions in the urology field. Our team comprises exceptionally skilled and accomplished individuals from the medical device industry, all driven by a passion to make a difference in kidney stone care. We take pride in our collaborative, diverse, enjoyable, and ever-evolving work environment. Our actions are guided by our core values, which we refer to as 'F.I.T to WIN.' Find Joy: We celebrate victories and appreciate the journey. Integrity: We adhere to honesty, honor, and reliability. Transparency: We maintain open and honest communication, sharing information throughout our organization. Win as a Team: We actively collaborate, holding both ourselves and each other accountable.
Calyxo has raised $123M across 3 funding rounds on record, the most recent a Series F of $40.0M announced in Apr 2026.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Calyxo Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Calyxo Funding Rounds
Calyxo raised $32.7M in a Series C announced in Jul 2022.
1.3 years later, an undisclosed round of $50.0M was announced in Nov 2023.
2.4 years later, a Series F of $40.0M was announced in Apr 2026.
Calyxo Founders and Leadership Team
No contact details are on record for this team yet.
Calyxo Funding Compared to Other Health Care Startups
Calyxo's latest round of $40.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Calyxo in Health Care and Pleasanton
Companies Similar to Calyxo
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Calyxo Funding FAQs
What does Calyxo do?
Calyxo, Inc. is an innovative healthcare company that focuses on enhancing the treatment of kidney stones, a prevalent and distressing condition that currently requires significant healthcare resources. Established in 2016, Calyxo is guided by experienced leaders and investors who have successfully introduced groundbreaking solutions in the urology field. Our team comprises exceptionally skilled and accomplished individuals from the medical device industry, all driven by a passion to make a difference in kidney stone care. We take pride in our collaborative, diverse, enjoyable, and ever-evolving work environment. Our actions are guided by our core values, which we refer to as 'F.I.T to WIN.' Find Joy: We celebrate victories and appreciate the journey. Integrity: We adhere to honesty, honor, and reliability. Transparency: We maintain open and honest communication, sharing information throughout our organization. Win as a Team: We actively collaborate, holding both ourselves and each other accountable.
How much funding has Calyxo raised?
Calyxo has raised $123M across 3 rounds on record. The most recent is a Series F of $40.0M announced in Apr 2026.
When did Calyxo last raise funding?
Calyxo's most recent funding round on record is a Series F of $40.0M, announced in Apr 2026.
Who founded Calyxo?
FundedIQ lists Jee Shin (Founder), Joe Catanese (Founder) at Calyxo.
Where is Calyxo headquartered?
Calyxo is based in Pleasanton, California, United States.
How many employees does Calyxo have?
Calyxo is in the 51-100 employee band.
How does Calyxo's funding compare to other Health Care startups?
Calyxo's latest round of $40.0M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Calyxo Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Calyxo is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.